期刊文献+

CAG方案治疗老年急性髓性白血病的临床观察 被引量:3

下载PDF
导出
摘要 目的观察CAG方案治疗老年急性髓性白血病的临床疗效和不良反应,并与既往常规DA方案进行比较分析。方法选择153例老年AML患者,近年的78例采用CAG方案,既往75例采用标准DA方案化疗。结果 78例患者中CR 66例,PR 4例,余8例未缓解,总有效率为89.7%,CR率和总有效率均显著高于常规DA方案治疗。CAG方案治疗组骨髓抑制与感染率较常规方案治疗组有明显差异(P<0.05)。结论 CAG方案治疗老年急性髓性白血病,疗效确切,是有效、安全的诱导治疗方案。
出处 《中国医药指南》 2014年第35期248-249,共2页 Guide of China Medicine
  • 相关文献

参考文献3

  • 1张建军,于登祥,徐俊,王志生.TA方案治疗老年急性髓系白血病[J].白血病.淋巴瘤,2004,13(6):360-361. 被引量:6
  • 2Bai A,Kojima H,Hori M,et al.Priming with G-CSF effectively enhances low-dose Ara-C-induced in vivo apoptosis in myeloid leukemia cells[J].Exp Hematol,1999,27(2):259-265.
  • 3Yamada K,Furusawa S,Saito K.Concurrent use of granulocyte colony-stimulating factor with low-dose cytosine arabinoside and aclarubicin for previously treated acute myelogenous leukemia:a pilot study[J].Leukemia,1995,9(1):10-14.

二级参考文献2

  • 1Lancet J E, Willman C L, Bennett J M. Acute myelogenous leukemia and aging clinical interactions [J]. Hematol Onco Clin North Am, 2000, 14:251-267.
  • 2Foon R A, Zigheboim J, Yale C, et al. Intensive chemotherapy is the treatment of choice for elderly patients with acute myelogenous leukemia[J]. Blood, 1981, 58:467.

共引文献5

同被引文献35

  • 1郭良耀,赵小亭,李葳.小剂量AA方案并G-CSF治疗老年急性髓性白血病疗效观察[J].白血病.淋巴瘤,2005,14(1):39-40. 被引量:2
  • 2魏旭东,刘艳艳,张丽娜,汪萍,张艳莉,朱兴虎,宋永平.CHG和CAG预激方案治疗复发、难治性急性髓系白血病疗效的比较[J].中华血液学杂志,2006,27(1):64-64. 被引量:27
  • 3邵彬,高彦荣,王椿,颜式可,蔡琦,姜杰玲,杨隽,白海涛,赵旻,赵初娴.77例老年急性髓性白血病患者的预后因素分析[J].癌症,2006,25(8):1007-1012. 被引量:7
  • 4陆米则,沈云峰,毛玉文.CAG方案治疗老年急性髓系白血病的疗效观察[J].临床血液学杂志,2007,20(3):173-174. 被引量:18
  • 5LaubachJ,RaoAV.Current and emerging strategies for the management of acute myeloid leukemia in the elderly [J].Oncologist,2008,13(10):1097-10108.doi:10.1634/theoncologist.2008-0100.
  • 6AppelbaumFR,GundackerH,HeadDR,et al.Age and acute myeloid leukemia[J].Blood,2006,107(9):3481-3485.
  • 7WeiG,NiW,ChiaoJW,et al.A meta-analysis of CAG(cytarabine,aclarubicin,G-CSF) regimen for the treatment of 1029 patients with acute myeloid leukemia and myelodysplastic syndrome [J].J Hematol Oncol,2011,4:46.doi:10.1186/1756-8722-4-46.
  • 8PautasC,MerabetF,ThomasX,et al.Randomized study of intensified anthracycline doses for induction and recombinant interleukin-2 for maintenance in patients with acute myeloid leukemia age 50 to 70 years:results of the ALFA-9801 study [J].J Clin Oncol,2010,28(5):808-814.doi:10.1200/JCO.2009.23.2652.
  • 9MAlfusonJV,EtienneA,TurlureP,et al.Risk factors and decision criteria for intensive chemotherapy in older patients with acute myeloid leukemia [J].Haematologica,2008,93(12):1806-1813.doi:10.3324/haematol.13309.
  • 10BennettJM,CatovskyD,DanialMT,et al.Proposed revised criteria for the classification of acute myeloid leukemia.A report of the French-American-British Cooperative Group [J].Ann Intern Med,1985,103(4):620-625.

引证文献3

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部